Back to Search Start Over

One Year Assessment of the Hearing Preservation Potential of the EVO Electrode Array

Authors :
Nicolas Guevara
Yann Nguyen
Benoit Godey
Chadlia Karoui
Marine Ardoint
Cécile Parietti-Winkler
Eric Truy
Isabelle Mosnier
Dan Gnansia
Michel Hoen
Valérie Franco-Vidal
Christophe Vincent
Université de Lille
Inserm
CHU Lille
Institut Universitaire de la Face et du Cou [Nice]
Centre Hospitalier Régional Universitaire de Nancy [CHRU Nancy]
CHU Pontchaillou [Rennes]
CHU de Bordeaux Pellegrin [Bordeaux]
Oticon Medical / Neurelec
Département d'ORL, chirurgie cervico-maxillo-faciale et d'audiophonologie [Hôpital Edouard Herriot - HCL]
Advanced Drug Delivery Systems (ADDS) - U1008
CHU Pitié-Salpêtrière [AP-HP]
Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)
Hôpital Edouard Herriot [CHU - HCL]
Hospices Civils de Lyon (HCL)-Hospices Civils de Lyon (HCL)
Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 (MBLC - ADDS)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Source :
Journal of Clinical Medicine; Volume 10; Issue 23; Pages: 5604, Journal of Clinical Medicine, Journal of Clinical Medicine, 2021, Journal of Clinical Medicine, 10 (23), pp.5604. ⟨10.3390/jcm10235604⟩, Journal of Clinical Medicine, Vol 10, Iss 5604, p 5604 (2021)
Publication Year :
2021
Publisher :
Multidisciplinary Digital Publishing Institute, 2021.

Abstract

Background: A prospective longitudinal multicentre study was conducted to assess the one-year postsurgical hearing preservation profile of the EVOTM electrode array. Methods: Fifteen adults presenting indications of electro-acoustic stimulation (pure-tone audiometry (PTA) thresholds ≤70 dB below 750 Hz) were implanted with the EVO™ electrode array. Hearing thresholds were collected at five time-points from CI activation to twelve months (12M) after activation. Hearing thresholds and hearing preservation profiles (HEARRING group classification) were assessed. Results: All subjects had measurable hearing thresholds at follow-up. No case of complete loss of hearing or minimal hearing preservation was reported at any time point. At activation (Nact = 15), five participants had complete hearing preservation, and ten participants had partial hearing preservation. At the 12M time point (N12m = 6), three participants had complete hearing preservation, and three participants had partial hearing preservation. Mean hearing loss at activation was 11 dB for full range PTA and 25 dB for PTAs low-frequency (125–500 Hz). Conclusions: This study provides the first longitudinal follow-up on associated hearing profiles to the EVO™ electrode array, which are comparable to the literature. However, other studies on larger populations should be performed.

Details

Language :
English
ISSN :
20770383
Database :
OpenAIRE
Journal :
Journal of Clinical Medicine; Volume 10; Issue 23; Pages: 5604
Accession number :
edsair.doi.dedup.....fc4b67e3fdf6979242eaf7ee90585bf7
Full Text :
https://doi.org/10.3390/jcm10235604